Biocia and I-MED Pharma Consummate a Long-Term R&D Agreement With Matrix Biology Institute
Biocia Inc. and I-MED Pharma Inc. have strengthen their foothold in global ophthalmic eye markets with an alliance with MBI to develop innovative, state-of-the art products incorportaing MBI’s patented HylaSponge® technology.